• Lorista

  Form: tablets, film-coated

  Active substance	Dosage
  Losartan potassium	25 mg

  ATC: C09CA01

• Losartan hydrochlorothiazide krka

  Form: tablets, film-coated

  Active substance	Dosage
  Losartan potassium	50 mg
  Hydrochlorothiazide	12.5 mg

  ATC: C09DA01

• Losartan hydrochlorothiazide krka

  Form: tablets, film-coated

  Active substance	Dosage
  Losartan potassium	100 mg
  Hydrochlorothiazide	25 mg

  ATC: C09DA01

• Losartan krka

  Form: tablets, film-coated

  Active substance	Dosage
  Losartan potassium	25 mg

  ATC: C09CA01

• Losartan krka

  Form: tablets, film-coated

  Active substance	Dosage
  Losartan potassium	50 mg

  ATC: C09CA01

• Losartan krka

  Form: tablets, film-coated

  Active substance	Dosage
  Losartan potassium	100 mg

  ATC: C09CA01

• Lynxaram

  Form: tablets, film-coated

  Active substance	Dosage
  linagliptin	5 mg

  ATC: A10BH05

• Mexdagry

  Form: tablets, film-coated

  Active substance	Dosage
  dapagliflozin	5 mg
  metformin hydrochloride	1000 mg

  ATC: A10BD15

• Mexdagry

  Form: tablets, film-coated

  Active substance	Dosage
  dapagliflozin	5 mg
  metformin hydrochloride	850 mg

  ATC: A10BD15

• Mirzaten

  Form: tablets, film-coated

  Active substance	Dosage
  mirtazapine	30 mg

  ATC: N06AX11

• Mirzaten 30 mg

  Form: tablets, film-coated

  Active substance	Dosage
  mirtazapine	30 mg

  ATC: N06AX11

• Mirzaten 30 mg

  Form: tablets, film-coated

  Active substance	Dosage
  mirtazapine	30 mg

  ATC: N06AX11

• Mirzaten 30 mg

  Form: tablets, film-coated

  Active substance	Dosage
  mirtazapine	30 mg

  ATC: N06AX11

• Mirzaten 45 mg

  Form: tablets, film-coated

  Active substance	Dosage
  mirtazapine	45 mg

  ATC: N06AX11

• Mirzaten 45 mg

  Form: tablets, film-coated

  ATC: N06AX11

• Mirzaten q-tab

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  mirtazapine	30 mg

  ATC: N06AX11

• Mirzaten q-tab

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  mirtazapine	15 mg

  ATC: N06AX11

• Mirzaten q-tab

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  mirtazapine	45 mg

  ATC: N06AX11

• Naklofen

  Form: solution for injection

  Active substance	Dosage
  Sodium diclofenac	75 mg

  ATC: M01AB05

• Naklofen duo

  Form: capsules, modified release

  Active substance	Dosage
  sodium diclofenac	75 mg

  ATC: M01AB05

• Nalgesin

  Form: tablets, film-coated

  Active substance	Dosage
  Sodium naproxen	275 mg

  ATC: M01AE02

• Nalgesin forte

  Form: tablets, film-coated

  Active substance	Dosage
  sodium naproxen	550 mg

  ATC: M01AE02

• Nalgesin mini

  Form: tablets, film-coated

  Active substance	Dosage
  sodium naproxen	220 mg

  ATC: M01AE02

• Nebivolol krka

  Form: tablets

  Active substance	Dosage
  nebivolol	5 mg

  ATC: C07AB12

• Nolicin

  Form: tablets, film-coated

  Active substance	Dosage
  norfloxacin	400 mg

  ATC: J01MA06

• Nolicin

  Form: tablets, film-coated

  Active substance	Dosage
  norfloxacin	400 mg

  ATC: J01MA06

• Nolicin

  Form: tablets, film-coated

  Active substance	Dosage
  norfloxacin	400 mg

  ATC: J01MA06

• Nolicin

  Form: tablets, film-coated

  Active substance	Dosage
  norfloxacin	400 mg

  ATC: J01MA06

• Nolicin

  Form: tablets, film-coated

  Active substance	Dosage
  norfloxacin	400 mg

  ATC: J01MA06

• Nolpaza 20 mg tablets for oral use

  Form: tablets, enteric-coated

  Active substance	Dosage
  pantoprazole	20 mg

  ATC: A02BC02

• Nolpaza control

  Form: tablets, enteric-coated

  Active substance	Dosage
  pantoprazole	20 mg

  ATC: A02BC02

• Nolpaza control

  Form: tablets, enteric-coated

  Active substance	Dosage
  pantoprazole	20 mg

  ATC: A02BC02

• Nolpaza control

  Form: tablets, enteric-coated

  Active substance	Dosage
  pantoprazole	20 mg

  ATC: A02BC02

• Nolpaza control

  Form: tablets, enteric-coated

  Active substance	Dosage
  pantoprazole	20 mg

  ATC: A02BC02

• Olanzapine krka

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  olanzapine	7.5 mg

  ATC: N05AH03

• Olanzapine krka

  Form: tablets

  Active substance	Dosage
  olanzapine	15 mg

  ATC: N05AH03

• Olanzapine krka

  Form: tablets

  Active substance	Dosage
  olanzapine	10 mg

  ATC: N05AH03

• Olanzapine krka

  Form: tablets

  Active substance	Dosage
  olanzapine	5 mg

  ATC: N05AH03

• Olanzapine krka

  Form: tablets

  Active substance	Dosage
  olanzapine	20 mg

  ATC: N05AH03

• Olanzapine krka

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  olanzapine	5 mg

  ATC: N05AH03

• Olanzapine krka

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  olanzapine	15 mg

  ATC: N05AH03

• Olanzapine krka

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  olanzapine	20 mg

  ATC: N05AH03

• Olanzapine krka

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  olanzapine	10 mg

  ATC: N05AH03

• Olimestra

  Form: tablets, film-coated

  Active substance	Dosage
  olmesartan medoxomil	40 mg

  ATC: C09CA08

• Olimestra

  Form: tablets, film-coated

  Active substance	Dosage
  olmesartan medoxomil	20 mg

  ATC: C09CA08

• Olimestra

  Form: tablets, film-coated

  Active substance	Dosage
  Olmesartan medoxomil	10 mg

  ATC: C09CA08

• Parnido

  Form: tablets, prolonged release

  Active substance	Dosage
  paliperidone	9 mg

  ATC: N05AX13

• Parnido

  Form: tablets, prolonged release

  Active substance	Dosage
  paliperidone	6 mg

  ATC: N05AX13

• Parnido

  Form: tablets, prolonged release

  Active substance	Dosage
  paliperidone	3 mg

  ATC: N05AX13

• Perindopril

  Form: tablets

  Active substance	Dosage
  perindopril	No input provided

  ATC: C09AA04